Apexium Financial’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$1.61M 241
2023
Q4
$1.61M Buy
+100,000
New +$1.52M 0.12% 86

Other funds holding ECAT

Apexium Financial's ECAT Position: Q1 2024 in Review

Apexium Financial sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q1 2024, closing a stake of 100,000 shares — an estimated $1.61M sold.

Apexium Financial first reported a position in ECAT in Q4 2023 and held it in 1 quarter. The position peaked at $1.61M in Q4 2023. 71 funds tracked by Wall St. Rank hold ECAT as of Q1 2024.

  • Apexium Financial reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q1 2024 after selling out during the quarter.
  • Apexium Financial sold 100,000 BlackRock ESG Capital Allocation Term Trust shares in Q1 2024, an estimated $1.61M.
  • Apexium Financial first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2023 and held it in 1 quarter.
  • Apexium Financial's BlackRock ESG Capital Allocation Term Trust position peaked at $1.61M in Q4 2023.
  • 71 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2024.

Based on Apexium Financial's 13F filing for Q1 2024, filed 19 Apr 2024.